Lisa Schrewe
St. Josef Hospital
Bochum, NW, Germany
Bochum, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.
Journal: Acta neuropathologica
Published: December 07, 2018
Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study.
Journal: Therapeutic advances in neurological disorders
Published: October 24, 2018
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod.
Journal: CNS neuroscience & therapeutics
Published: June 14, 2018
1,25-OH2 vitamin D3 and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL).
Journal: Leukemia research reports
Published: July 10, 2017
Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection.
Journal: Journal of neuroinflammation
Published: February 23, 2017
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.
Journal: Journal of neuroinflammation
Published: April 08, 2015
Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis.
Journal: Journal of neuroimmunology
Published: May 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026